Revisiting vSGLT: Non-Radioactive Characterization of the Vibrio Na

Natalia Ermolova, Thorsten Althoff, Ernest M Wright, Jeff Abramson

Abstract read

In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Natalia ErmolovaDepartment of Physiology, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.

Thorsten AlthoffDepartment of Physiology, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.ORCID 0000-0001-5688-5328

Ernest M WrightDepartment of Physiology, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.ORCID 0000-0002-1023-4391

Jeff AbramsonDepartment of Physiology, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.

Funding

Deciphering molecular details of cellular sugar transport and their roles in diseaseR35GM135175 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Jeffrey S Abramson · 2022 to 2023

$1.5M

NIGMS NIH HHS R35 GM135175NIH HHS R35 GM135175

6 · The paper itself

Abstract

The sodium-galactose cotransporter from

Indexed as

Bacterial ProteinsSodium-Glucose Transport ProteinsVibrio parahaemolyticusBiological TransportFucoseGalactoseGlucoseHumansKineticsSodiumBacterial ProteinsFucoseGalactoseGlucoseSodiumSodium-Glucose Transport Proteinselectrogenic transportsodium–glucose couplingsolid-supported membrane electrophysiologyVibrio parahaemolyticus sodium–galactose transporter (vSGLT)

Identifiers

PMID41898650

DOI10.3390/ijms27062790

PMCPMC13026924

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.